We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.2B
AUM Growth
+$3.24B
(+7.1%)
Cap. Flow
+$512M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
15.87%
Holding
2,920
New
16
Increased
1,206
Reduced
1,586
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$23.3M |
| 2 |
Becton Dickinson
BDX
|
+$18.4M |
| 3 |
Amazon
AMZN
|
+$16.1M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$15.4M |
| 5 |
Johnson & Johnson
JNJ
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$48.1M |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$27.7M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
+$10.7M |
| 4 |
PRXL
Parexel International Corp
PRXL
|
+$10.3M |
| 5 |
CELG
Celgene Corp
CELG
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.9% |
| 2 | Technology | 16.24% |
| 3 | Healthcare | 13.01% |
| 4 | Industrials | 10.83% |
| 5 | Consumer Discretionary | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Frontline
FRO
$8.7B
| $359K | ﹤0.01% |
78,151
-13,724
| -15% | -$76.7K |
|
|
MOFG
2377
DELISTED
MidWestOne Financial Group
MOFG
| $358K | ﹤0.01% |
10,678
-1,994
| -16% | -$70.4K |
|
2378
Celldex Therapeutics
CLDX
$3.02B
| $357K | ﹤0.01% |
8,371
-1,537
| -16% | -$65.8K |
|
2379
Citizens & Northern Corp
CZNC
$456M
| $357K | ﹤0.01% |
14,884
-3,820
| -20% | -$95.3K |
|
2380
Natural Gas Services Group
NGS
$462M
| $357K | ﹤0.01% |
13,608
-2,230
| -14% | -$59.5K |
|
|
SN
2381
DELISTED
Sanchez Energy Corporation
SN
| $356K | ﹤0.01% |
66,977
-13,357
| -17% | -$63.2K |
|
2382
Mesa Laboratories
MLAB
$558M
| $355K | ﹤0.01% |
2,857
-660
| -19% | -$92.3K |
|
2383
Flexsteel Industries
FLXS
$301M
| $354K | ﹤0.01% |
7,567
-1,212
| -14% | -$59.3K |
|
2384
PennyMac Financial
PFSI
$3.94B
| $354K | ﹤0.01% |
15,855
-2,502
| -14% | -$49.3K |
|
|
ORC
2385
Orchid Island Capital
ORC
$1.32B
| $353K | ﹤0.01% |
7,601
-858
| -10% | -$42.2K |
|
2386
Snap
SNAP
$7.89B
| $351K | ﹤0.01% |
24,000
+1,100
| +5% | +$16K |
|
|
ONIT
2387
Onity Group
ONIT
$315M
| $351K | ﹤0.01% |
7,468
-1,403
| -16% | -$70.4K |
|
|
ACBI
2388
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $350K | ﹤0.01% |
19,875
-3,730
| -16% | -$64.2K |
|
2389
America's Car Mart
CRMT
$26.7M
| $349K | ﹤0.01% |
7,825
-1,104
| -12% | -$48.4K |
|
2390
Sonida Senior Living
SNDA
$1.9B
| $349K | ﹤0.01% |
1,723
-545
| -24% | -$117K |
|
|
QADA
2391
DELISTED
QAD Inc.
QADA
| $349K | ﹤0.01% |
8,992
-1,862
| -17% | -$70K |
|
2392
First Mid Bancshares
FMBH
$1.38B
| $348K | ﹤0.01% |
9,037
-1,796
| -17% | -$70.5K |
|
2393
RadNet
RDNT
$4.93B
| $346K | ﹤0.01% |
34,227
-6,520
| -16% | -$68K |
|
|
MRT
2394
DELISTED
MedEquities Realty Trust, Inc.
MRT
| $346K | ﹤0.01% |
30,882
-5,592
| -15% | -$63.4K |
|
2395
Digimarc Corp
DMRC
$146M
| $345K | ﹤0.01% |
9,537
-1,888
| -17% | -$68.6K |
|
|
DX
2396
Dynex Capital
DX
$3.18B
| $345K | ﹤0.01% |
16,427
-2,564
| -14% | -$54.9K |
|
|
TPCO
2397
DELISTED
Tribune Publishing Company Common Stock
TPCO
| $345K | ﹤0.01% |
19,620
-3,462
| -15% | -$56.1K |
|
|
FPI
2398
Farmland Partners
FPI
$411M
| $341K | ﹤0.01% |
39,288
-901
| -2% | -$8.08K |
|
|
TTPH
2399
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $341K | ﹤0.01% |
2,709
-171
| -6% | -$21.9K |
|
2400
Ichor Holdings
ICHR
$2.61B
| $339K | ﹤0.01% |
13,785
-717
| -5% | -$20.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, RhumbLine Advisers held 2,920 positions worth $49.2B, up 7.1% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2017: portfolio turnover was 3.5%. RhumbLine Advisers opened 16 new positions and exited 85, leaving the 2,920-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 187,382 shares worth $9.83M.
- RhumbLine Advisers added most to Microsoft in Q4 2017, an estimated $23.3M increase.
- RhumbLine Advisers's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.2M.
- RhumbLine Advisers fully exited CR Bard Inc. in Q4 2017, selling an estimated $48.1M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $49.2B portfolio in Q4 2017.
- RhumbLine Advisers opened 16 new positions and closed 85 in Q4 2017.
- RhumbLine Advisers's portfolio value rose 7.1% quarter-over-quarter to $49.2B.
Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.